{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:07:22Z","timestamp":1790417242603,"version":"4.1.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 NS43985"],"award-info":[{"award-number":["P01 NS43985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20RR15635"],"award-info":[{"award-number":["P20RR15635"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PO1 NS31492"],"award-info":[{"award-number":["PO1 NS31492"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS034239"],"award-info":[{"award-number":["R01NS034239"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37 NS36126"],"award-info":[{"award-number":["R37 NS36126"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.nbd.2009.12.015","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T04:09:01Z","timestamp":1262664541000},"page":"542-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["HIV-1 neuroimmunity in the era of antiretroviral therapy"],"prefix":"10.1016","volume":"37","author":[{"given":"Stephanie D.","family":"Kraft-Terry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Stothert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Buch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.nbd.2009.12.015_bib1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/01.aids.0000279702.71062.52","article-title":"Combining prevention, treatment and care: lessons from South Africa","volume":"21","author":"Achmat","year":"2007","journal-title":"Aids"},{"key":"10.1016\/j.nbd.2009.12.015_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/157016208785861195","article-title":"Cellular reservoirs of HIV-1 and their role in viral persistence","volume":"6","author":"Alexaki","year":"2008","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.nbd.2009.12.015_bib3","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1016\/j.vaccine.2009.05.028","article-title":"Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination","volume":"27","author":"Aline","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.nbd.2009.12.015_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2006-956759","article-title":"Dementia and neurocognitive disorders due to HIV-1 infection","volume":"27","author":"Ances","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.nbd.2009.12.015_bib5","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1523\/JNEUROSCI.1933-04.2004","article-title":"Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis","volume":"24","author":"Anderson","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.12.015_bib6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/sj.jcbfm.9600115","article-title":"Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells","volume":"25","author":"Andras","year":"2005","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.nbd.2009.12.015_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2007.02.012","article-title":"Dichotomous effects of C\u2013C chemokines in HIV-1 pathogenesis","volume":"110","author":"Ansari","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.nbd.2009.12.015_bib8","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2009.12.015_bib9","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/01.aids.0000327635.74919.fd","article-title":"Costs and benefits of HAART for patients with HIV in a public hospital in Mexico","volume":"22","author":"Aracena-Genao","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.nbd.2009.12.015_bib10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0166-2236(99)01453-8","article-title":"Chemokines in the CNS: plurifunctional mediators in diverse states","volume":"22","author":"Asensio","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2009.12.015_bib11","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1128\/JVI.75.15.7067-7077.2001","article-title":"Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10\/IP-10 gene expression by astrocytes in vivo and in vitro","volume":"75","author":"Asensio","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2009.12.015_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jneuroim.2004.08.025","article-title":"Neuroimaging correlates of HIV-associated BBB compromise","volume":"157","author":"Avison","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejpb.2009.03.006","article-title":"Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment","volume":"72","author":"Baert","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.nbd.2009.12.015_bib14","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/eji.200939451","article-title":"CTL quality and the control of human retroviral infections","volume":"39","author":"Bangham","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib15","doi-asserted-by":"crossref","first-page":"E1158","DOI":"10.1152\/ajpendo.2000.278.6.E1158","article-title":"Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice","volume":"278","author":"Banks","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2009.12.015_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuroscience.2004.06.021","article-title":"Binding, internalization, and membrane incorporation of human immunodeficiency virus-1 at the blood\u2013brain barrier is differentially regulated","volume":"128","author":"Banks","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2009.12.015_bib17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4414\/smw.2009.12662","article-title":"Morbidity and mortality in HIV-infected individuals\u2014a shift towards comorbidities","volume":"139","author":"Battegay","year":"2009","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.nbd.2009.12.015_bib18","first-page":"4","article-title":"Facilitated monocyte\u2013macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles","volume":"e4343","author":"Beduneau","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2009.12.015_bib19","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1172\/JCI25444","article-title":"Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor","volume":"115","author":"Bellizzi","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2009.12.015_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2217\/17435889.3.3.357","article-title":"Intracellular delivery of nanoparticles via the HIV-1 tat peptide","volume":"3","author":"Berry","year":"2008","journal-title":"Nanomed"},{"key":"10.1016\/j.nbd.2009.12.015_bib21","first-page":"147","article-title":"Viral reservoirs and HIV-specific immunity","volume":"1","author":"Blankson","year":"2006","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.nbd.2009.12.015_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-5728(97)00158-6","article-title":"Primary sensory neurons migrate in response to the chemokine RANTES","volume":"81","author":"Bolin","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2362.2006.01657.x","article-title":"Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia","volume":"36","author":"Brabers","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.nbd.2009.12.015_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11481-006-9023-5","article-title":"Drugs of abuse, immune modulation, and AIDS","volume":"1","author":"Cabral","year":"2006","journal-title":"J. Neuroimmune. Pharmacol."},{"key":"10.1016\/j.nbd.2009.12.015_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/aid.2008.0140","article-title":"Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression","volume":"25","author":"Cao","year":"2009","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.nbd.2009.12.015_bib26","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/597801","article-title":"Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells","volume":"199","author":"Card","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.nbd.2009.12.015_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2009.09.002","article-title":"Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system","volume":"287","author":"Christo","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"Suppl. 4","key":"10.1016\/j.nbd.2009.12.015_bib28","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/01.aids.0000279710.47298.5c","article-title":"Access to diagnostics in support of HIV\/AIDS and tuberculosis treatment in developing countries","volume":"21","author":"Cohen","year":"2007","journal-title":"Aids"},{"key":"10.1016\/j.nbd.2009.12.015_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1742-4690-6-51","article-title":"HIV interactions with monocytes and dendritic cells: viral latency and reservoirs","volume":"6","author":"Coleman","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.nbd.2009.12.015_bib30","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1073\/pnas.95.6.3117","article-title":"Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia","volume":"95","author":"Conant","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.12.015_bib31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/ijms10031045","article-title":"Molecular pathology of neuro-AIDS (CNS-HIV)","volume":"10","author":"Crews","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2009.12.015_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11065-009-9092-3","article-title":"Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review","volume":"19","author":"Cysique","year":"2009","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.nbd.2009.12.015_bib33","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","article-title":"Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy","volume":"73","author":"Cysique","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2009.12.015_bib34","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0002-9440(10)65511-3","article-title":"Blood\u2013brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis","volume":"155","author":"Dallasta","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2009.12.015_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon. Cytokine Res."},{"key":"10.1016\/j.nbd.2009.12.015_bib36","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.2741\/2979","article-title":"Roles of MCP-1 in development of HIV-dementia","volume":"13","author":"Dhillon","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.nbd.2009.12.015_bib37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4049\/jimmunol.0900274","article-title":"Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS","volume":"183","author":"Dou","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib38","doi-asserted-by":"crossref","unstructured":"Eggert, D., et al., 2010. Neuroprotective activities of CEP-1346 in models of neuroAIDS. Journal of Immunology. 184, 746\u2013756.","DOI":"10.4049\/jimmunol.0902962"},{"key":"10.1016\/j.nbd.2009.12.015_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jneuroim.2009.06.002","article-title":"Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders","volume":"213","author":"Eggert","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib40","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.4049\/jimmunol.178.10.6581","article-title":"The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo","volume":"178","author":"Ellery","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib41","doi-asserted-by":"crossref","first-page":"12844","DOI":"10.1523\/JNEUROSCI.4154-07.2007","article-title":"Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes","volume":"27","author":"Eugenin","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.12.015_bib42","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1046\/j.1471-4159.2003.01775.x","article-title":"MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis","volume":"85","author":"Eugenin","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.12.015_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13550280903131915","article-title":"Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy","author":"Everall","year":"2009","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.nbd.2009.12.015_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF03033819","article-title":"The shifting patterns of HIV encephalitis neuropathology","volume":"8","author":"Everall","year":"2005","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2009.12.015_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405010239","article-title":"Evolving paradigms in the pathogenesis of HIV-1-associated dementia","volume":"7","author":"Fischer-Smith","year":"2005","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.nbd.2009.12.015_bib46","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/13550280802132857","article-title":"Monocyte\/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies","volume":"14","author":"Fischer-Smith","year":"2008","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.nbd.2009.12.015_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/aid.2007.0193","article-title":"CD163\/CD16 coexpression by circulating monocytes\/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression","volume":"24","author":"Fischer-Smith","year":"2008","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.nbd.2009.12.015_bib48","doi-asserted-by":"crossref","first-page":"7086","DOI":"10.1073\/pnas.82.20.7086","article-title":"Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow","volume":"82","author":"Gendelman","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.12.015_bib49","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/515693","article-title":"Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia","volume":"178","author":"Gendelman","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.nbd.2009.12.015_bib50","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1084\/jem.176.6.1703","article-title":"Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage\u2013astroglia interactions: implications for the neuropathogenesis of HIV disease","volume":"176","author":"Genis","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2009.12.015_bib51","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.4049\/jimmunol.0801450","article-title":"Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance","volume":"182","author":"Giri","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1471-4159.2005.03431.x","article-title":"Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1\/CCL2 of GABA-induced currents in spinal cord neurones","volume":"95","author":"Gosselin","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.12.015_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/10717540802321776","article-title":"Polymeric nanoparticles for enhancing antiretroviral drug therapy","volume":"15","author":"Govender","year":"2008","journal-title":"Drug Deliv."},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2009.12.015_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13550280500511741","article-title":"Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment","volume":"11","author":"Gray","year":"2005","journal-title":"J. Neurovirol"},{"key":"10.1016\/j.nbd.2009.12.015_bib55","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0264-410X(02)00089-0","article-title":"The advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes","volume":"20","author":"Gruters","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.nbd.2009.12.015_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1570162043485077","article-title":"CD8+ T-cells: function and response to HIV infection","volume":"2","author":"Gulzar","year":"2004","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.nbd.2009.12.015_bib57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/322130a0","article-title":"Pathogenesis of lentivirus infections","volume":"322","author":"Haase","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2009.12.015_bib58","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-02-204263","article-title":"The level of monocyte turnover predicts disease progression in the macaque model of AIDS","author":"Hasegawa","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.nbd.2009.12.015_bib59","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4049\/jimmunol.160.2.877","article-title":"Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity","volume":"160","author":"Hesselgesser","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2009.04.006","article-title":"CD 4+ T cells in the pathobiology of neurodegenerative disorders","volume":"211","author":"Huang","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib61","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1378\/chest.08-0364","article-title":"Changing global epidemiology of pulmonary manifestations of HIV\/AIDS","volume":"134","author":"Hull","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.nbd.2009.12.015_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/13550280902769764","article-title":"Acquired immunodeficiency syndrome and the blood\u2013brain barrier","volume":"15","author":"Ivey","year":"2009","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.nbd.2009.12.015_bib63","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1086\/518443","article-title":"CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection","volume":"196","author":"Jaworowski","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.nbd.2009.12.015_bib64","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00005072-199806000-00004","article-title":"Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement","volume":"57","author":"Jones","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.12.015_bib65","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/jnen\/61.11.992","article-title":"HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia","volume":"61","author":"Kanmogne","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.12.015_bib66","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnen\/64.6.498","article-title":"HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia","volume":"64","author":"Kanmogne","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.12.015_bib67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/157016209788347976","article-title":"Emerging of HIV drug resistance: epidemiology, diagnosis, treatment and prevention","volume":"7","author":"Kiertiburanakul","year":"2009","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.nbd.2009.12.015_bib68","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2353\/ajpath.2006.050215","article-title":"CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood","volume":"168","author":"Kim","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2009.12.015_bib69","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/aid.2006.0162","article-title":"CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro","volume":"23","author":"Kinter","year":"2007","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.nbd.2009.12.015_bib70","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0165-5728(98)00223-9","article-title":"Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10","volume":"93","author":"Kolb","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib71","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.virusres.2005.04.009","article-title":"Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus","volume":"111","author":"Kramer-Hammerle","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.nbd.2009.12.015_bib72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuron.2009.09.042","article-title":"A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection","volume":"65","author":"Kraft-Terry","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2009.12.015_bib73","article-title":"Social and structural determinants of HAART access and adherence among injection drug users","author":"Krusi","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.nbd.2009.12.015_bib74","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1750-3639.2003.tb00010.x","article-title":"HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era","volume":"13","author":"Lambotte","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2009.12.015_bib75","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1750-3639.2003.tb00019.x","article-title":"Changing patterns in the neuropathogenesis of HIV during the HAART era","volume":"13","author":"Langford","year":"2003","journal-title":"Brain. Pathol."},{"key":"10.1016\/j.nbd.2009.12.015_bib76","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2009.12.015_bib77","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.4049\/jimmunol.0803330","article-title":"Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration","volume":"182","author":"Liu","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2004.08.031","article-title":"Cerebrospinal fluid markers that predict SIV CNS disease","volume":"157","author":"Mankowski","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib79","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","article-title":"Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance","volume":"23","author":"Marra","year":"2009","journal-title":"Aids"},{"key":"10.1016\/j.nbd.2009.12.015_bib80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1615\/CritRevNeurobiol.v10.i1.30","article-title":"Pathogenesis of HIV-1 associated neurodegeneration","volume":"10","author":"Masliah","year":"1996","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2009.12.015_bib81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2796.2008.02054.x","article-title":"Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location","volume":"265","author":"Masopust","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.nbd.2009.12.015_bib82","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1474-4422(05)70165-4","article-title":"Neurological complications of HIV infection","volume":"4","author":"McArthur","year":"2005","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.nbd.2009.12.015_bib83","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1310\/AW2H-TP5C-NP43-K6BY","article-title":"HIV pharmacology: barriers to the eradication of HIV from the CNS","volume":"7","author":"McGee","year":"2006","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.nbd.2009.12.015_bib84","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2008.04.022","article-title":"Chemokines and neuromodulation","volume":"198","author":"Melik-Parsadaniantz","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib85","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1073\/pnas.95.24.14500","article-title":"Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity","volume":"95","author":"Meucci","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.12.015_bib86","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1073\/pnas.090017497","article-title":"Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival","volume":"97","author":"Meucci","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.12.015_bib87","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0166-2236(99)01408-3","article-title":"AIDS and the brain: is there a chemokine connection?","volume":"22","author":"Miller","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2009.12.015_bib88","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jneuroim.2005.07.012","article-title":"Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma","volume":"169","author":"Monteiro de Almeida","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2006.06.018","article-title":"Relationship of CSF leukocytosis to compartmentalized changes in MCP-1\/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy","volume":"179","author":"Monteiro de Almeida","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib90","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0167-5699(95)80022-0","article-title":"Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive\/motor complex","volume":"16","author":"Nottet","year":"1995","journal-title":"Immunol. Today"},{"key":"10.1016\/j.nbd.2009.12.015_bib91","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.4049\/jimmunol.156.3.1284","article-title":"Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain","volume":"156","author":"Nottet","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib92","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2217\/nnm.09.38","article-title":"NanoART, neuroAIDS and CNS drug delivery","volume":"4","author":"Nowacek","year":"2009","journal-title":"Nanomed"},{"key":"10.1016\/j.nbd.2009.12.015_bib93","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7861\/clinmedicine.8-5-539","article-title":"Common AIDS-associated opportunistic infections","volume":"8","author":"Ong","year":"2008","journal-title":"Clin. Med."},{"key":"10.1016\/j.nbd.2009.12.015_bib94","doi-asserted-by":"crossref","first-page":"57","DOI":"10.14712\/18059694.2016.105","article-title":"Scavenger receptor CD163 and its biological functions","volume":"52","author":"Onofre","year":"2009","journal-title":"Acta Medica (Hradec. Kralove)"},{"key":"10.1016\/j.nbd.2009.12.015_bib95","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1460-9568.2008.06444.x","article-title":"Mechanisms of platelet-derived growth factor-mediated neuroprotection\u2013implications in HIV dementia","volume":"28","author":"Peng","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2009.12.015_bib96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF03033827","article-title":"Adjunctive therapies for HIV-1 associated neurologic disease","volume":"8","author":"Perry","year":"2005","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2009.12.015_bib97","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.4049\/jimmunol.158.7.3499","article-title":"A model for monocyte migration through the blood\u2013brain barrier during HIV-1 encephalitis","volume":"158","author":"Persidsky","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib98","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0002-9440(10)65476-4","article-title":"Microglial and astrocyte chemokines regulate monocyte migration through the blood\u2013brain barrier in human immunodeficiency virus-1 encephalitis","volume":"155","author":"Persidsky","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2009.12.015_bib99","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1189\/jlb.68.3.413","article-title":"Mononuclear phagocytes mediate blood\u2013brain barrier compromise and neuronal injury during HIV-1-associated dementia","volume":"68","author":"Persidsky","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.nbd.2009.12.015_bib100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","article-title":"Blood\u2013brain barrier: structural components and function under physiologic and pathologic conditions","volume":"1","author":"Persidsky","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.nbd.2009.12.015_bib101","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00005072-198611000-00003","article-title":"Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review","volume":"45","author":"Petito","year":"1986","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.12.015_bib102","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/13550280600879204","article-title":"Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome","volume":"12","author":"Petito","year":"2006","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.nbd.2009.12.015_bib103","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.4049\/jimmunol.168.8.3941","article-title":"Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis","volume":"168","author":"Poluektova","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib104","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0002-9440(10)63344-5","article-title":"Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis","volume":"165","author":"Potula","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2009.12.015_bib105","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/sj.jcbfm.9600125","article-title":"HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK 1\/2 activation","volume":"25","author":"Pu","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2009.12.015_bib106","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/jnen\/63.12.1255","article-title":"CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE)","volume":"63","author":"Roberts","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2009.12.015_bib107","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nrn2255","article-title":"Chemokines: a new class of neuromodulator?","volume":"8","author":"Rostene","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2009.12.015_bib108","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.4049\/jimmunol.161.8.4169","article-title":"Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV","volume":"161","author":"Ruiz","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib109","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.wnl.0000204294.28189.03","article-title":"Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report","volume":"66","author":"Schifitto","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2009.12.015_bib110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/13550280902758973","article-title":"Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment","volume":"15","author":"Schifitto","year":"2009","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.nbd.2009.12.015_bib111","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1086\/421244","article-title":"Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection","volume":"189","author":"Shacklett","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.nbd.2009.12.015_bib112","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0046-8177(85)80245-8","article-title":"Multinucleated giant cells and HTLV-III in AIDS encephalopathy","volume":"16","author":"Sharer","year":"1985","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.nbd.2009.12.015_bib113","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2353\/ajpath.2009.081010","article-title":"Genetically modified CD34+ hematopoietic stem cells contribute to turnover of brain perivascular macrophages in long-term repopulated primates","volume":"174","author":"Soulas","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2009.12.015_bib114","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1471-4159.2003.01543.x","article-title":"HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium","volume":"84","author":"Toborek","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.12.015_bib115","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4049\/jimmunol.164.3.1333","article-title":"Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system","volume":"164","author":"Tong","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib116","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/eji.200839002","article-title":"Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population","volume":"39","author":"Torheim","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2009.12.015_bib117","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1089\/aid.2007.0263","article-title":"Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection?","volume":"24","author":"Tsoupras","year":"2008","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.nbd.2009.12.015_bib118","doi-asserted-by":"crossref","first-page":"A99","DOI":"10.1016\/j.antiviral.2008.12.013","article-title":"The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research","volume":"82","author":"Varatharajan","year":"2009","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.nbd.2009.12.015_bib119","doi-asserted-by":"crossref","first-page":"19182","DOI":"10.1073\/pnas.0604678103","article-title":"Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration","volume":"103","author":"Vergote","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.12.015_bib120","first-page":"3","article-title":"Proteomic modeling for HIV-1 infected microglia\u2013astrocyte crosstalk","volume":"e2507","author":"Wang","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2009.12.015_bib121","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11481-008-9110-x","article-title":"HIV-1-infected astrocytes and the microglial proteome","volume":"3","author":"Wang","year":"2008","journal-title":"J. Neuroimmune. Pharmacol."},{"key":"10.1016\/j.nbd.2009.12.015_bib122","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1189\/jlb.0808501","article-title":"Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages","volume":"85","author":"Westhorpe","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.nbd.2009.12.015_bib123","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-009-9174-2","article-title":"CNS inflammation and macrophage\/microglial biology associated with HIV-1 infection","author":"Yadav","year":"2009","journal-title":"J. Neuroimmune. Pharmacol."},{"key":"10.1016\/j.nbd.2009.12.015_bib124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/rmv.577","article-title":"Anti-HIV adaptive immunity: determinants for viral persistence","volume":"18","author":"Yamamoto","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.nbd.2009.12.015_bib125","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.2781-08.2009","article-title":"Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity","volume":"29","author":"Yao","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2009.12.015_bib126","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00019052-199708000-00007","article-title":"The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes","volume":"10","author":"Zheng","year":"1997","journal-title":"Curr. Opin. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109003702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109003702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:06:22Z","timestamp":1760850382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996109003702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":126,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0969996109003702"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2009.12.015","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 neuroimmunity in the era of antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2009.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}